Wegovy firm unexpectedly forces boss to step down

Wegovy公司意外迫使老板辞职

World Business Report

新闻

2025-05-17

26 分钟
PDF

单集简介 ...

Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the popular weight-loss drug market. Consumer boycotts of countries and companies are on the rise, with the latest being an Indian tourism boycott of Turkey and Azerbaijan. This comes as some Canadians boycott the US, while others refuse to buy from some specific companies over their policies. And Rahul Tandon hears about why some private companies in the USA see an opportunity in this rail sector, as there are concerns over the US federal government looking to pull back from supporting rail.
更多

单集文稿 ...

  • Hello and welcome to World Business Report here on the BBC World Service.

  • I'm Rahul Tandon.

  • Plenty coming up on this edition.

  • More and more consumers are boycotting products from countries for political reasons.

  • But does that actually work?

  • Boycotting a whole country is hard.

  • Boycotting a specific product when there are easy alternatives is much, much easier.

  • And should the US invest more in its rail network?

  • But we're going to start the programme.

  • by talking about this company.

  • Type 2 diabetes?

  • Discover the Ozempic Trizone.

  • I got the power of three.

  • The weight loss drug Ozempic has turned the Danish pharmaceutical company Novo Nordisk into one of the most profitable firms in Europe.

  • Briefly, in 2024, it was actually Europe's most valuable company.

  • And the sales of weight loss drugs have had a huge impact on the Danish economy.

  • Here's the mayor of Kronenberg, the town where its manufacturing hub,

  • Ten years ago, we had quite high unemployment rate.

  • Now we have one of the lowest in the island of Sealand.

  • All the people working there, they have a good salary and they can pay taxes.